A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of novel drug targets. In a...
Scientists at deCODE genetics, a subsidiary of Amgen, in collaboration with researchers at the National University Hospital of Iceland, have published a study on a cardiac electrical abnormality that can potentially result in sudden cardiac death. The study, recently...
A study from deCODE genetics reveals the first genetic locus for voice pitch. Kari Stefansson senior author and CEO of deCODE genetics and Rosa S. Gisladottir first author on the paper. In a paper published today in Science Advances, an international team led by...
Join host Ray Deshaies, Amgen’s senior vice president of Global Research, who speaks with Dr. Kári Stefánsson, M.D., founder, of deCODE genetics about the Role of Human Diversity in Progressing Precision Medicine s Amgen R&D’s next podcast series, Human Data Era,...
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). Kari Stefansson CEO of deCODE genetics and senior author on the paper and Gardar...
